Category: Events

Meet Spear Bio at AAIC 2026

Discover new SPEAR UltraDetect™ assay and instrument innovations for Alzheimer’s and neurodegenerative biomarker research Spear Bio is excited to exhibit at the Alzheimer’s Association International Conference® 2026 in London. Visit us at Booth 322 to learn how SPEAR immunoassays are advancing ultra-sensitive, low-volume biomarker measurement across Alzheimer’s disease, neurodegeneration, and preclinical research. At AAIC 2026, Spear Bio will introduce […]

Read More

Meet Spear Bio at the 5th ALS Drug Development Summit

June 2nd – June 4th, 2026 Boston, MA Spear Bio is attending the 5th ALS Drug Development Summit, taking place June 2-4, 2026 in Boston, MA, where leaders across biotech, pharma, academia, clinical development, regulatory science, and patient advocacy will come together to accelerate the next generation of ALS and FTD therapeutics.  As ALS and FTD programs […]

Read More

Enhance Neurodegenerative Detection and Monitoring with BD-pTau 217 and α-Syn

Tuesday, May 12, 2026 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central) The ability to reliably detect blood-based biomarkers such as brain-derived pTau 217 (BD-pTau 217) and α-synuclein species across healthy and disease populations has remained a significant challenge in neurodegenerative disease research. Recent advances in ultra-sensitive immunoassay technology are now […]

Read More

AD/PD™ Alzheimer’s & Parkinson’s Diseases Conference 2026

Join Spear Bio at AD/PD™ 2026Spear Bio is proud to sponsor and participate in AD/PD™ 2026: International Conference on Alzheimer’s and Parkinson’s Diseases, taking place in Copenhagen, Denmark, from March 17-21, 2026.  This conference is where the brightest minds gather to explore the latest research, clinical trials, and treatments for Alzheimer’s and Parkinson’s. From uncovering groundbreaking discoveries to […]

Read More

GAP-Net Site Optimization Conference 2026

As the largest North American network of private and institution-based neurodegenerative disease clinical trial sites, the annual GAP-Net Site Optimization conference offers a unique interaction and multi-directional dialogue among all partners. The reciprocal communication experienced by attendees is critical to the success of the clinical trials we conduct, offering opportunities for people involved in all […]

Read More

Alzheimer’s & Parkinson’s Drug Development Summit

February 3-5, 2026 | Boston, MA The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies. However, as challenges remain in the clinical adoption of Lecanemab and Donanemab, the field needs to navigate the move towards disease-modifying therapeutics. Capitalizing […]

Read More

Enhanced early Alzheimer’s detection with the novel SPEAR UltraDetect pTau 217 Assay

Friday, January 30 at 10:00 EST | 07:00 PST | 15:00 GMT | 16:00 CET This SelectScience webinar will highlight how the SPEAR UltraDetect™ platform enables ultra-sensitive and highly specific detection of plasma pTau 217 for enhanced accuracy of early Alzheimer’s detection.  Attendees will gain an overview of how SPEAR UltraDetect pTau 217 performance compares […]

Read More

Meet Spear Bio at SfN 2025 — Booth #3211 in San Diego

Experience the Future of Ultra-Performance Protein Detection Join Spear Bio at the Society for Neuroscience (SfN) 2025 Annual Meeting, taking place November 15–19 at the San Diego Convention Center. Visit Booth #3211 to see how our SPEAR UltraDetect™ homogeneous, wash-free immunoassay platform is enabling ultra-sensitive, ultra-precision protein measurement— empowering neuroscientists to uncover new insights into […]

Read More

Alzheimer’s Association International Conference (AAIC) 2025

Spear Bio at the 2025 Alzheimer’s Association International Conference (AAIC): Advancing Alzheimer’s Disease Biomarker Research Spear Bio is proud to sponsor the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto, Canada, July 27–30. Join us as we unveil our new SPEAR UltraDetect™ Assay portfolio—designed to accelerate discovery and advance Alzheimer’s disease research. Revolutionizing Biomarker Research […]

Read More

AD/PD™ Alzheimer’s & Parkinson’s Diseases Conference 2025

Spear Bio at the 2025 AD/PD™ Conference: Advancing Alzheimer’s & Parkinson’s Disease Research Spear Bio is excited to sponsor the 2025 AD/PD™ Alzheimer’s & Parkinson’s Diseases Conference in Vienna, Austria, from April 1-5. In addition, we’re showcasing our latest innovations to help researchers make breakthroughs in these challenging diseases. Revolutionizing Biomarker Research with SPEAR Technology […]

Read More